Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast

Applied Immunohistochemistry

Volumn 8, Issue 1, 2000, Pages 32-36

  Lele, Subodh M ^a   Graves, Kerry ^a   Gatalica, Zoran ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Actin; Maspin; Metallothionein; Myoepithelium; Myofibroblast; Radial sclerosing lesion; S 100 protein; Tubular carcinoma

Indexed keywords

MASPIN;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BREAST; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOTHIONEIN; PROTEINS; SCLEROSIS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034118370     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200003000-00005     Document Type: Article

References (21)

1. Gottlieb C, Raju U, Greenawald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol 1990;3:135-40.
2. Gould VE, Miller J, Jao W. Ultrastructure of medullary, intraductal, tubular and adenocystic breast carcinomas. Am J Pathol 1975;78:401-16.
3. Harris M, Ahmed A. The ultrastructure of tubular carcinoma of the breast. J Pathol 1977;123:79-83.
4. Jao W, Recant W, Swerdlow MA. Comparative ultrastructure of tubular carcinoma and sclerosing adenosis of the breast. Cancer 1976;38:180-6.
5. Joshi MG, Lee AKC, Pedersen CA, Schnitt S, Camus MG, Hughes KS. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 1996;9:57-62.
6. Oberman HA, Fidler WJ Jr. Tubular carcinoma of the breast. Am J Surg Pathol 1979;3:387-95.
7. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: normal breast and benign proliferative lesions. Virchows Archiv A Pathol Anat Histopathol 1992;421:315-22.
8. Egan MJ, Newman J, Crocker J, Collard M. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast. Arch Pathol Lab Med 1987;111:28-31.
9. Ahmed A. The myofibroblast in breast disease. Pathol Annu 1990;25(pt 2):237-86.
10. Wang NP, Wan BC, Skelly M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997;5:141-51.
11. Dwarakanath S, Lee AK, DeLellis RA, Silverman ML, Frasca L, Wolfe HJ. S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol 1987; 18:1144-8.
12. Raju UB, Lee MW, Zarbo RJ, Crissman JD. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 1989;2:569-76.
13. Zou Z, Anisowicz A, Hendrix MJC, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-9.
14. Sager R, Sheng S, Pemberton P, Hendrix MJ. Maspin. A tumor suppressing serpin. Adv Exp Med Biol 1997;425:77-88.
15. Nath R, Kambadur R, Gulati S, Paliwal VK, Sharma M. Molecular aspects, physiological functions, and clinical significance of metallothioneins. Crit Rev Food Sci Nutr 1988;27:41-85.
16. Bier B, Douglas-Jones A, Totsch M, et al. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant lesions. Breast Cancer Res Treat 1994; 30:213-21.
17. Zhang PJ, Nolan C, Driscoll DL, Maggio P, Brooks JJ. Maspin, a prognostic marker for breast cancer? [Abstract] Mod Pathol 1998; 11:31A.
18. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in-situ. Pathol Res Pract 1997; 193:753-8.
19. Luppi M, Morselli M, Bandieri E, et al. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 1996;7:619-24.
20. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A 1996; 93:11669-74.
21. Stemlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 1997;3:1949-58.